Live tape
Top 8, mentions 7d10,382TSLA2,416 mentions▲ +0.05SPCX1,886 mentions▲ +0.08GOOGL1,298 mentions▲ +0.04CRWV1,186 mentions▲ +0.04NVDA1,045 mentions▲ +0.07QQQ1,010 mentions▲ +0.05META776 mentions▲ +0.05NBIS765 mentions▲ +0.07

Equity · Healthcare

AHCO

NASDAQ

AdaptHealth (AHCO)

$5.87 −2.65% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026
Price · Chart
62 sessions
$12 $4 23 Jul 19 Oct

The line runs $10.48 on 23 July through $5.87 on 19 October, on a scale from $4 to $12. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 62 sessions, 23 Jul – 19 Oct 2026
Market cap $800.3M
52-week range $5.22 – $13.39
Avg volume 163.3K

as of Oct 19, 2026

AdaptHealth (AHCO) insider trades

SEC Form 4 · last 90 days · newest reported trade 6 Aug 2026

In the 90 days to 21 Oct 2026, AdaptHealth insiders reported 2 open-market purchases and no sales (SEC Form 4).

Open-market buys 2
Open-market sells 0
Net bought $276K
Non-trade filings 1
Date Insider Type Shares Value
06 Aug 2026 WOLF DALE B Director Buy 20,000 $126K
06 Aug 2026 SAMET KENNETH A Director Buy 23,500 $150K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
09 Sep 2026 CURRIE HARRISS T CHIEF FINANCIAL OFFICER Award 141,372

AdaptHealth (AHCO) reported financials

SEC EDGAR XBRL SEC EDGAR

AdaptHealth reported revenue of $3.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$70.8M.

Figure Reported Period
Revenue $3.2B 31 Dec 2025 fiscal year
Net income −$70.8M 31 Dec 2025 fiscal year
Diluted EPS −$0.52 31 Dec 2025 fiscal year
Total assets $4.3B 30 Jun 2026 at period end
Total equity $1.4B 30 Jun 2026 at period end

AdaptHealth (AHCO) earnings

SEC EDGAR

AdaptHealth last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.99; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.99 $740M
31 Mar 2026 Q1 2026 −$0.12 $820M
31 Dec 2025 FY 2025 −$0.52 $3.24B
30 Sep 2025 Q3 2025 $0.16 $820M
30 Jun 2025 Q2 2025 $0.10 $657M
31 Mar 2025 Q1 2025 −$0.05 $778M
31 Dec 2024 FY 2024 $0.61 $3.26B
30 Sep 2024 Q3 2024 $0.15 $806M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AdaptHealth (AHCO) institutional holders (13F)

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a AdaptHealth position for the quarter ended 30 Jun 2026 — a combined $32.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Added +234.7% shares 764,342 $8.0M
AQR Capital Management Held (±25%) −21.2% shares 761,857 $7.9M
Citadel Advisors Added +275.4% shares 484,652 $5.1M
D. E. Shaw & Co. Held (±25%) +21.5% shares 407,617 $4.2M
Millennium Management Trimmed −47.4% shares 347,920 $3.6M
Man Group Trimmed −30.0% shares 290,028 $3.0M
Balyasny Asset Management Trimmed −51.7% shares 74,969 $781K
Two Sigma Investments Added +45.7% shares 27,401 $286K
Marshall Wace Exited

AdaptHealth (AHCO) fails-to-deliver

SEC CNS data SEC

On 14 Sep 2026, 1,370 shares of AdaptHealth failed to deliver (about $8K).

Settlement date Shares failed Notional % of shares out
14 Sep 2026 1,370 $8K 0.001%
10 Sep 2026 152 $866 <0.001%
09 Sep 2026 287 $2K <0.001%

Congressional trades in AdaptHealth (AHCO)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in AdaptHealth is a sale by Kevin Hern (house, OK), dated 06 Apr 2023.

Date Member Type Amount
06 Apr 2023 filed 11 May 2023 Kevin Hern house · Republican–OK Sale $1K–$15K
30 Nov 2022 filed 29 Dec 2022 Susie Lee house · Democrat–NV Sale $1K–$15K
22 Apr 2022 filed 12 May 2022 Kevin Hern house · Republican–OK Sale $1K–$15K
25 Aug 2021 filed 15 Sep 2021 Kevin Hern house · Republican–OK Purchase $100K–$250K
20 May 2021 filed 15 Jun 2021 Kevin Hern house · Republican–OK Purchase $1K–$15K
09 Feb 2021 filed 11 Mar 2021 Susie Lee house · Democrat–NV Purchase $1K–$15K
05 Jan 2021 filed 10 Feb 2021 Susie Lee house · Democrat–NV Purchase $1K–$15K

AdaptHealth (AHCO): frequently asked questions

From live data

Have AdaptHealth insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, AdaptHealth insiders reported 2 open-market purchases and no sales (SEC Form 4). A further 1 filing was a grant, award, gift or exercise rather than an open-market trade.

How many institutions hold AdaptHealth?

8 of the 45 institutional funds we track reported a AdaptHealth position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has AdaptHealth had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for AdaptHealth is dated 14 Sep 2026, when 1,370 shares failed to deliver.

When did AdaptHealth last report earnings?

AdaptHealth last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.99; no next date is announced in SEC filings yet.

What exchange is AdaptHealth listed on?

AdaptHealth trades on NASDAQ under the ticker AHCO.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings